At a glance
ClinicalIndex Comparison RecordN/ACompleted· 424 enrolled
Drug / intervention
Rectal and buccal swabsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pancreatitis - Microbiome As Predictor of Severity
In Brief
A clinical study evaluating Rectal and buccal swabs for Acute Pancreatitis. Completed, enrolled 424 participants across 1 site.
Detailed Summary
This study is a multicentric prospective study initiated and coordinated from the University Medical Centre Goettingen. The study aims to evaluate the orointestinal microbiome as a potential biomarker for the course, severity and outcome of patients with acute pancreatitis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Pancreatitis
CountriesGermany
CollaboratorsUniversity Medical Center Rostock, Medical Department II, Division of Gastroenterology, University Hospital of Leipzig, Ludwig-Maximilians - University of Munich, Department of Medicine I, University Hospital of Halle, Department of Medicine A, University Medicine Greifswald, Technical University of Munich, Department of Medical Bioinformatics, University Medical Center Göttingen, Department if Medical Statistics, University Medical Center Göttingen
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartFeb 2020
First PostedMar 2021
Primary CompletionSep 2023
Study CompletionFeb 2024
TodayJul 2026
First PostedMar 2, 2021
Enrollment StartFeb 17, 2020
Primary CompletionSep 30, 2023
Study CompletionFeb 23, 2024
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 5.3 years ago
Interventions
Rectal and buccal swabsother
The oral and intestinal flora is collected from buccal and rectal swabs.